Yes — starting HIV treatment early helps prevention. When someone with HIV takes antiretroviral therapy (ART) and reaches an undetectable viral load, they will not pass HIV to sex partners. This is called U=U (undetectable equals untransmittable). Treating early also protects the person's own health.
in 2023
≈723,000 — U=U
| Item | Value |
|---|---|
| New diagnoses | 38,800 — in 2023 |
| Living with HIV | 1.12 million |
| Virally suppressed | ~65% — ≈723,000 — U=U |
| On PrEP | 381,000 |
Why treating early works as prevention
HIV is a virus that attacks the immune system, and the amount of virus in the blood — the viral load — drives how contagious a person is CDC, About HIV. In the acute stage, the first few weeks after infection, the viral load spikes above a million copies per milliliter, and onward transmission risk peaks right then StatPearls. ART suppresses that viral load. Once it falls below the threshold labs call undetectable (under 200 copies/mL), the virus can no longer be passed on through sex.
This isn't a hopeful theory. Across the PARTNER, Opposites Attract, and PARTNER2 studies, mixed-status couples logged more than 125,000 condomless sex acts while the partner with HIV was virally suppressed, with zero linked HIV transmissions Lancet, PARTNER. Most people who start ART reach undetectable within about six months CDC, U=U. The sooner treatment starts, the sooner that protection kicks in, for the person and for everyone they're intimate with.
How HIV is treated
Everyone diagnosed with HIV should start ART as soon as possible after diagnosis, and treatment is lifelong CDC, HIV Treatment. ART combines HIV medicines from different drug classes — integrase inhibitors, NRTIs, NNRTIs, and protease inhibitors — that hit the virus at different points in its life cycle. Many people take a single daily pill that combines several drugs; others take a combination of pills. Every regimen aims to drive the viral load down to undetectable and keep it there.
Your clinician picks the specific combination based on your health, other medications, and lab work, so I'll keep doses out of this page. For the full breakdown of how the regimens and drug classes work, see our guide to hiv treatment.
What treatment is actually like
For most people now, daily ART means one pill a day, far simpler than the regimens of decades past. Modern HIV is compatible with a near-normal lifespan: a 20-year-old who starts treatment before their CD4 count drops below 200 has a life expectancy approaching that of the general population Lancet HIV. The earlier you begin, the more of your immune system you preserve.
Sticking with it matters every day. An undetectable viral load is treatment-dependent control: latent HIV hides in cells and tissues, and the virus rebounds if treatment stops HHS clinicalinfo.hiv.gov. Missing doses can let the virus replicate and develop resistance, which narrows your future options. HIV is now a manageable, long-term condition, but only if you take the medicine consistently.
Is there a cure?
No. There's no effective cure, and people who get HIV have it for life — ART controls the virus but doesn't eradicate it NIAID. Researchers separate a sterilizing cure (removing all replication-competent virus) from a functional cure (the virus persists but stays controlled without ongoing ART); neither is available today NIAID, remission. A handful of people — the Berlin patient, the London patient, and a New York woman documented as the third case and the first woman — reached long-term remission after stem-cell transplants done to treat cancer, using rare HIV-resistant donor cells NIH, 2022. Those procedures are high-risk and not a scalable cure. A cure is blocked mainly by that latent reservoir, and approaches like 'shock and kill,' gene editing, and broadly neutralizing antibodies are still in research.
What about partners?
HIV isn't treated with a single partner-treatment course the way some bacterial STIs are. Protection has two parts: you reach and maintain an undetectable viral load so you can't transmit, and partners without HIV can protect themselves with PrEP. Telling a partner about an HIV diagnosis can feel daunting; we cover how to approach it honestly in our piece on the ethics of hiv disclosure.
If a partner thinks they were exposed very recently, PEP is the emergency option — a 28-day course that must start within 72 hours of exposure and cut HIV seroconversion by about 81% in the original occupational study CDC, PEP. That's an urgent-care or ER conversation today, not a wait-and-see one. Going forward, partners can switch to PrEP for ongoing protection.
Follow-up and monitoring
There's no 'test of cure' for HIV because it isn't cured; instead, treatment is monitored. Your clinician tracks your viral load to confirm it drops to undetectable and stays there, and your CD4 count to confirm your immune system is recovering. Once you're stable and suppressed, visits typically space out, but they never stop, because stopping ART lets the virus rebound. Reaching and holding undetectable is the milestone that protects your health and makes you untransmittable.
What happens if HIV goes untreated
Untreated, HIV moves through three stages. The acute stage brings a high viral load and, in about 9 in 10 people, flu-like symptoms two to four weeks after infection — fever, sore throat, swollen glands, rash — exactly when the person is most contagious. Those symptoms look identical to the flu, and some people get none at all, so only a test can confirm or rule out HIV.
Next comes chronic infection (clinical latency), where the virus stays active but a person may feel fine. Untreated, this can last a decade or more while the immune system is slowly eroded. The final, most severe stage is AIDS, defined by a CD4 count under 200 cells/mm³ or an opportunistic infection (an illness that takes hold because the immune system can no longer defend the body). Early treatment keeps a person from ever reaching that stage.
Prevention going forward
Treatment-as-prevention (U=U) is one of the CDC's core prevention tools, alongside condoms, PrEP, PEP, and regular testing CDC, How HIV Spreads. For people without HIV, here's how the main options compare:
| Tool | Who it's for | How it's taken | Effectiveness |
|---|---|---|---|
| Treatment / U=U | People living with HIV | Daily ART, lifelong | Zero transmissions while undetectable aidsmap |
| Oral PrEP (Truvada/Descovy) | HIV-negative people at risk through sex or injection | Daily pill | ~99% lower risk from sex when taken as prescribed CDC, PrEP |
| Injectable PrEP (cabotegravir) | HIV-negative people at risk | Shot every 2 months after two starter doses | Outperformed daily pills in trials |
| PEP | After a possible exposure | 28-day course within 72 hours | Emergency use only |
One caution on PrEP: Descovy is not approved for people at risk through receptive vaginal sex or for those who inject drugs, while Truvada covers all those routes. PrEP also requires a confirmed HIV-negative test before starting, because beginning PrEP with undiagnosed HIV risks drug resistance. Newer long-acting options keep raising the bar; twice-yearly injectable lenacapavir produced zero infections among women in the PURPOSE 1 trial WHO. Perinatal HIV is also highly preventable: with ART during pregnancy and labor plus newborn prophylaxis, mother-to-child transmission risk drops to under 1%.
When to see a clinician
Get tested if you've had a possible exposure, new or multiple partners, or any flu-like illness after a risk — and know the when to test after exposure timing so you don't test too early. If you think you were exposed in the last three days, don't wait for symptoms or a test: go to urgent care or the ER and ask about PEP today. Diagnosis rates are highest across the South and in Washington DC CDC AtlasPlus, 2023, but anyone can acquire HIV, and the only way to know your status is to test. Ready when you are — you can get tested or compare testing providers.